Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.2010
Nov 18 • 3:59 PM ET Dollar change+0.0109 Percentage change(5.73%)
Aftermarket Close
0.2240
Aftermarket • 5:00 PM ET Dollar change+0.0230 Percentage change(11.44%)
Index
-
Market Cap
12.83M
Enterprise Value
259.57M
Income
-50.83M
Sales
222.77M
Book/sh
0.02
Cash/sh
0.14
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
562
IPO
Mar 22, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
0.06
P/B
8.71
P/C
1.47
P/FCF
0.19
EV/EBITDA
17.42
EV/Sales
1.17
Quick Ratio
0.49
Current Ratio
0.70
Debt/Eq
9.92
LT Debt/Eq
2.66
Option/Short
Yes / Yes
EPS (ttm)
-0.80
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -47.12%
Sales past 3/5Y
-17.23% 2.85%
EPS Y/Y TTM
13.29%
Sales Y/Y TTM
-29.98%
EPS Q/Q
-34.37%
Sales Q/Q
-30.39%
Insider Own
18.15%
Insider Trans
0.00%
Inst Own
21.49%
Inst Trans
-2.48%
ROA
-9.32%
ROE
-38.89%
ROIC
-59.20%
Gross Margin
36.13%
Oper. Margin
-4.58%
Profit Margin
-22.82%
SMA20
-10.10%
SMA50
-32.16%
SMA200
-51.32%
Trades
Shs Outstand
63.82M
Shs Float
52.23M
52W High
1.73 -88.39%
52W Low
0.18 10.87%
Volatility
11.87% 16.91%
ATR (14)
0.03
RSI (14)
38.92
Beta
0.57
Rel Volume
0.61
Avg Volume
313.32K
Volume
190,736
Perf Week
-13.62%
Perf Month
-20.17%
Perf Quarter
-55.32%
Perf Half Y
-53.27%
Perf YTD
-84.66%
Perf Year
-87.67%
Perf 3Y
-98.29%
Perf 5Y
-98.73%
Perf 10Y
-
Prev Close
0.19
Price
0.20
Change %
5.73%
Consensus
Hold
Avg. Price Target
$2.00
Implied Upside
+895.0%
Analysts5incl. previous ratings
Rating Distribution3 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 22, 2025Downgrade
OPY logoOOppenheimer
Outperform → Perform
Sep 10, 2025Downgrade
CCanaccord Genuity
Buy → Hold$2.50+1,143.8%
Jul 19, 2024Resumed
CCanaccord Genuity
Buy$17+8,357.7%
Jul 02, 2024Resumed
RROTH MKM
Buy$15+7,362.7%
Apr 06, 2023Initiated
OPY logoOOppenheimer
Outperform$15+7,362.7%
Sep 30, 2022Initiated
CCanaccord Genuity
Buy$22.50+11,094.0%
Oct 08, 2021Initiated
RROTH Capital
Buy$21+10,347.8%
Mar 15, 2021Initiated
LLake Street
Buy$15+7,362.7%
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment deals with the development and commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments in order to increase crop productivity and create value for customers. The Crop Protection segment develops and produces adjuvants, insecticides and fungicides. The Crop Nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops and of fertilizers including bio fertilizers and micro granulated fertilizers that increases the productivity and yield of the crops. The company was founded on November 14, 2017 and is headquartered in Rosario, Argentina.
General Counsel & Chief Compliance OfficerJose A. Roque
CEO & Executive DirectorDr. Federico Trucco Ph.D.
Chief Financial OfficerMr. Ezequiel Simmermacher
Principal Accounting OfficerMr. Alejandro Villafane
Head of Investor RelationsMs. Maria Paula Savanti